Source link : https://www.newshealth.biz/health-news/nipocalimab-reduces-igg-appears-safe-for-myasthenia-gravis-in-adolescents/
Investigational nipocalimab reduced serum immunoglobulin G (IgG), improved functional scores, and was well tolerated in adolescents with generalized myasthenia gravis, according to data from an open-label study presented at the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) annual meeting. In this exclusive MedPage Today video, Jonathan Strober, MD, of the UCSF Benioff Children’s Hospital […]
Author : News Health
Publish date : 2024-11-12 18:15:48
Copyright for syndicated content belongs to the linked Source.
inHealth